PRESS RELEASES
The service marks displayed on this site, including but not limited to KINDREDŽ, KINDRED HEALTHCAREŽ, and the KINDRED HEALTHCAREŽ logo, are the intellectual property of Kindred Healthcare, Inc. and are protected by applicable law.  Nothing contained on this site should be construed as granting, by implication, estoppel, or otherwise, any license or right to use any service mark displayed on the site without the prior express written permission of Kindred Healthcare, Inc.

KINDRED HEALTHCARE COMMENTS ON PROPOSED MEDICARE PAYMENT CHANGES FOR LONG-TERM ACUTE CARE HOSPITALS

Louisville, KY (January 20, 2006) – Kindred Healthcare, Inc. (the “Company”) (NYSE: KND) today announced that the Centers for Medicare and Medicaid Services ("CMS") issued late yesterday proposed regulatory changes regarding Medicare reimbursement for long-term acute care hospitals. The proposed rule would be effective for discharges occurring on or after July 1, 2006 through June 30, 2007. The proposed rule is subject to a 60-day public comment period.

The proposed rule is significant and the Company is continuing to evaluate the impact of this complex rule on its operations and its hospital development activities. For the nine months ended September 30, 2005, Medicare revenues in the Company’s hospitals approximated $822 million.

When management has completed its analysis of the proposed rule, it will provide additional guidance on its potential impact to the Company. In addition, the Company, in conjunction with its trade associations and other advocacy groups, intends to submit its comments in opposition to the proposed rule during the 60-day public comment period.

This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding the Company’s expected future financial position, results of operations, cash flows, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management and statements containing the words such as “anticipate,” “approximate,” “believe,” “plan,” “estimate,” “expect,” “project,” “could,” “should,” “will,” “intend,” “may” and other similar expressions, are forward-looking statements.

Such forward-looking statements are inherently uncertain, and stockholders and other potential investors must recognize that actual results may differ materially from the Company’s expectations as a result of a variety of factors, including, without limitation, those discussed below. Such forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to differ materially from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks, uncertainties and other factors discussed below and detailed from time to time in the Company’s filings with the Securities and Exchange Commission.

In addition to the factors set forth above, other factors that may affect the Company’s plans or results include, without limitation, (a) the Company’s ability to obtain lender commitments to increase its credit capacity; (b) the Company’s ability to operate pursuant to the terms of its debt obligations and its master lease agreements with Ventas, Inc. (NYSE: VTR); (c) the Company’s ability to meet its rental and debt service obligations; (d) adverse developments with respect to the Company’s results of operations or liquidity; (e) the Company’s ability to attract and retain key executives and other healthcare personnel; (f) increased operating costs due to shortages in qualified nurses and other healthcare personnel; (g) the effects of healthcare reform and government regulations, interpretation of regulations and changes in the nature and enforcement of regulations governing the healthcare industry; (h) changes in the reimbursement rates or methods of payment from third party payors, including the Medicare and Medicaid programs, and changes arising from the Medicare prospective payment system for long-term acute care hospitals and the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, and potential changes in nursing center Medicare reimbursement resulting from revised resource utilization grouping payments; (i) national and regional economic conditions, including their effect on the availability and cost of labor, materials and other services; (j) the Company’s ability to control costs, including labor and employee benefit costs; (k) the Company’s ability to comply with the terms of its Corporate Integrity Agreement; (l) the Company’s ability to successfully pursue its development activities and successfully integrate new operations, including the realization of anticipated revenues, economies of scale, cost savings and productivity gains associated with such operations; (m) the increase in the costs of defending and insuring against alleged professional liability claims and the Company’s ability to predict the estimated costs related to such claims; (n) the Company’s ability to successfully reduce (by divestiture of operations or otherwise) its exposure to professional liability claims; (o) the Company’s ability to successfully dispose of unprofitable facilities; and (p) the Company’s ability to ensure and maintain an effective system of internal controls over financial reporting. Many of these factors are beyond the Company’s control. The Company cautions investors that any forward-looking statements made by the Company are not guarantees of future performance. The Company disclaims any obligation to update any such factors or to announce publicly the results of any revisions to any of the forward-looking statements to reflect future events or developments.

Kindred Healthcare, Inc. through its subsidiaries operates hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business across the United States.

CONTACT:
Richard A. Lechleiter
Executive Vice President and Chief Financial Officer
(502) 596-7734

Return to Press Releases

Return to Home Page